Show
Sort by
-
- Journal Article
- A1
- open access
Did we overreact? Insights on COVID-19 disease and vaccination in a large cohort of immune-mediated inflammatory disease patients during sequential phases of the pandemic (the BELCOMID study)
-
- Journal Article
- A1
- open access
FLEXiGUT : rationale for exposomics associations with chronic low-grade gut inflammation
-
- Journal Article
- A1
- open access
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2)
-
- Journal Article
- A1
- open access
Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases
-
- Journal Article
- A1
- open access
Translational research into the effects of cigarette smoke on inflammatory mediators and epithelial TRPV1 in Crohn’s disease
-
Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases
-
Structural activation of pro-inflammatory human cytokine IL-23 by cognate IL-23 receptor enables recruitment of the shared receptor IL-12Rβ1
-
Should we target TNF receptors in the intestinal epithelium with glucocorticoids during systemic inflammation?
-
- Journal Article
- A1
- open access
Glucocorticoid receptor dimers control intestinal STAT1 and TNF-induced inflammation in mice
-
Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission